Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
May 26, 2020	FWP	FWP	View HTML 0001104659-20-065593.pdf
Aug 07, 2020	FWP	FWP	View HTML 0001104659-20-092011.pdf 0001104659-20-092011.xls
Mar 20, 2001	POS EX	POS EX	View HTML 0000950123-01-500272.pdf
Nov 17, 2004	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001206774-04-001651.pdf 0001206774-04-001651.xls
Mar 16, 2015	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001047469-15-002291.pdf 0001047469-15-002291.xls
Nov 08, 2001	PRES14A	A preliminary proxy statement giving notice regarding a special meeting	View HTML 0000950123-01-508078.pdf
May 19, 2015	PX14A6G	Notice of exempt solicitation. Definitive material	View HTML 0001140361-15-020862.pdf
May 18, 2023	PX14A6G	Notice of exempt solicitation. Definitive material	View HTML 0001214659-23-007448.pdf
Sep 16, 2003	REGDEX	REGDEX	View HTML 9999999997-03-036110.pdf
Dec 14, 2004	S-3	Simplified registration form	View HTML 0000950123-04-014750.pdf 0000950123-04-014750.xls

Data provided by Kaleidoscope.

Investors & Media